A
Akoya Biosciences Inc
NASDAQ:AKYA
Akoya Biosciences Inc
NASDAQ:AKYA
Price:
4.04 USD
1.25%
Market Closed
Updated:
May 4, 2024
Akoya Biosciences Inc
Cash from Financing Activities
|
Akoya Biosciences Inc
Cash from Financing Activities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Akoya Biosciences Inc
NASDAQ:AKYA
|
Cash from Financing Activities
$56.8m
|
CAGR 3-Years
118%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Akoya Biosciences Inc's Cash from Financing Activities?
Cash from Financing Activities
56.8m
USD
56.8m
USD
Based on the financial report for Dec 31, 2023, Akoya Biosciences Inc's Cash from Financing Activities amounts to 56.8m USD.
What is Akoya Biosciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
118%
118%
Over the last year, the Cash from Financing Activities growth was 98%. The average annual Cash from Financing Activities growth rates for Akoya Biosciences Inc have been 118% over the past three years .
You don't have any saved screeners yet
